These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11490231

  • 21. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [Abstract] [Full Text] [Related]

  • 22. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.
    Urol Int; 2009 May; 82(3):280-5. PubMed ID: 19440014
    [Abstract] [Full Text] [Related]

  • 23. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 24. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 25. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
    Chan TY, Chan DY, Stutzman KL, Epstein JI.
    J Urol; 2001 Dec 01; 166(6):2181-4. PubMed ID: 11696731
    [Abstract] [Full Text] [Related]

  • 26. Use of extended pattern technique for initial prostate biopsy.
    Siu W, Dunn RL, Shah RB, Wei JT.
    J Urol; 2005 Aug 01; 174(2):505-9. PubMed ID: 16006881
    [Abstract] [Full Text] [Related]

  • 27. Patients with low prostate-specific antigen levels (< or =4 ng/ml) would benefit from a twelve-core biopsy protocol for prostate cancer detection.
    Thiesler T, Trinkler F, Horcic M, Willi N, Cathomas G, Hailemariam S.
    Urol Int; 2007 Aug 01; 78(4):318-22. PubMed ID: 17495489
    [Abstract] [Full Text] [Related]

  • 28. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1520-9. PubMed ID: 15050332
    [Abstract] [Full Text] [Related]

  • 29. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    Ploussard G, Dubosq F, Boublil V, Allory Y, de la Taille A, Vordos D, Hoznek A, Abbou CC, Salomon L.
    J Urol; 2009 Oct 01; 182(4):1342-9. PubMed ID: 19683310
    [Abstract] [Full Text] [Related]

  • 30. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun 01; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

  • 31. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2004 Jun 01; 11(6):402-6. PubMed ID: 15157210
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy.
    Uemura H, Nakamura M, Hasumi H, Sugiura S, Fujinami K, Miyoshi Y, Yao M, Kubota Y.
    Int J Urol; 2004 Jul 01; 11(7):494-500. PubMed ID: 15242358
    [Abstract] [Full Text] [Related]

  • 33. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score.
    Elabbady AA, Khedr MM.
    Eur Urol; 2006 Jan 01; 49(1):49-53; discussion 53. PubMed ID: 16314035
    [Abstract] [Full Text] [Related]

  • 34. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels.
    Yang JC, Tang J, Li J, Luo Y, Li Y, Shi H.
    Acad Radiol; 2008 Oct 01; 15(10):1291-7. PubMed ID: 18790401
    [Abstract] [Full Text] [Related]

  • 35. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J, Hanchanale V, Foster CS, Javlé P.
    BJU Int; 2006 Sep 01; 98(3):559-62. PubMed ID: 16925754
    [Abstract] [Full Text] [Related]

  • 36. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies.
    Pal RP, Elmussareh M, Chanawani M, Khan MA.
    BJU Int; 2012 Feb 01; 109(3):367-71. PubMed ID: 21883818
    [Abstract] [Full Text] [Related]

  • 37. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 38. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY.
    Urol Int; 2009 Dec 01; 82(3):270-5. PubMed ID: 19440012
    [Abstract] [Full Text] [Related]

  • 39. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
    Krejcarek SC, Chen MH, Renshaw AA, Loffredo M, Sussman B, D'Amico AV.
    Urology; 2007 Mar 01; 69(3):515-9. PubMed ID: 17382156
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.